HYPER Corporation and BREDIS Healthcare Sign Strategic Partnership for Life-Stage AI Healthcare Solutions

HYPER Corporation (KRW 1,870, ▲2, +0.11%) announced on the 8th that it has signed a strategic memorandum of understanding (MOU) with senior healthcare solution company BREDIS Healthcare. The two companies plan to collaborate on a life-stage AI solution business addressing the challenges of a low birth rate and aging population. Through this agreement, BREDIS Healthcare becomes the first company to join the Hyper Life Care consortium. Hyper Life Care is a life solution unveiled by HYPER Corporation on the 26th, which aggregates life-cycle data through a consortium of participating companies to provide care for all generations. The two companies aim to build an ecosystem for senior total life care and family healthcare. To this end, they plan to share expertise in brain-cognitive health, general healthcare, and early dementia diagnosis and prevention in order to expand senior databases across both online and offline markets. Going forward, they will also jointly develop care solutions and programs addressing the needs of all generations to drive business growth. "We are delighted to partner with BREDIS Healthcare in building a care ecosystem suited to an era of low birth rates and an aging population," said Sangseok Lee, CEO of HYPER Corporation. "Through close collaboration, we will build a diverse life database and expand the Hyper Life Care consortium, growing into the largest holder of life data in Korea." Jina Kim, CEO of BREDIS Healthcare, said, "In Asian cultures grappling with the demographic challenges of our time, the synergy between HYPER Corporation's life database and our advanced blood testing and lifelog solutions has the potential to create significant social impact."